USDAR Principal Investigator
Massachusetts General Hospital (MGH) is one of the first academic medical centers established in the United States, known for innovations in health care and research.
Each year, MGH is recognized for achieving the highest standards in patient care, education, and research. MGH works to provide care in all corners of the world – locally, nationally, and globally – by partnering with underserved communities to build, improve, and sustain healthier communities.
MGH allergists and immunologists provide state-of-the-art care to patients with all major types of allergic and immunology disorders, led by clinical director Dr. Aleena Banerji. The Drug Allergy and Desensitization Program examines patients’ drug allergies to first-line, and often life-saving, medications, ranging from antibiotics to chemotherapeutics. Patients are evaluated by trained allergy experts to ensure they can safely receive their indicated therapies with limited possibility of adverse reactions.
Part of the MGH Mongan Institute, researchers conduct studies related to allergic and rheumatologic conditions using advanced informatics, clinical epidemiology, primary data collection, and simulation science.
